scispace - formally typeset
O

Ozden Sanal

Researcher at Hacettepe University

Publications -  187
Citations -  15270

Ozden Sanal is an academic researcher from Hacettepe University. The author has contributed to research in topics: Immunodeficiency & Primary immunodeficiency. The author has an hindex of 46, co-authored 186 publications receiving 14237 citations. Previous affiliations of Ozden Sanal include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Griscelli syndrome types 1 and 3: analysis of four new cases and long-term evaluation of previously diagnosed patients.

TL;DR: The authors' two new type 1 and two type 3 patients along with the progresses of the previously diagnosed patients with GS types 1 and 3 are described.
Journal ArticleDOI

Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease

TL;DR: This gene is localized on chromosome 16q24, encompasses 8·5 kb and contains six exons and encodes the alpha polypeptide of cytochrome b558, a key transmembrane protein in the phagocyte NADPH oxidase system.
Journal ArticleDOI

The effect of mannose-binding protein gene polymorphisms in recurrent respiratory system infections in children and lung tuberculosis.

TL;DR: The frequencies of the MBL gene variants in the Turkish population were determined and the presence of any association between MBL variants and development of tuberculosis (TB) in adults and recurrent respiratory tract infections in children was examined.
Journal ArticleDOI

A case of chronic severe neutropenia: Oral findings and consequences of short‐term granulocyte colony‐stimulating factor treatment

TL;DR: It is suggested that G-CSF together with dental care regimens is a promising treatment model in chronic severe neutropenia cases presenting with oral manifestations.
Journal ArticleDOI

Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency

TL;DR: Patients with recurrent infections, erythematous desquamative skin lesions, malar rash and oral mucosal involvement should be screened for complement Clq deficiency.